Team:RAMNOTIREN CALGARY
From 2014hs.igem.org
Line 159: | Line 159: | ||
#notebutt{ | #notebutt{ | ||
position: relative; | position: relative; | ||
- | top: | + | top: -300px; |
+ | left: 286px; | ||
background-color: #e6e6e6; | background-color: #e6e6e6; | ||
- | padding: 0px 15px | + | padding: 0px 15px 20px 15px; |
border-radius: 5px; | border-radius: 5px; | ||
} | } | ||
Line 169: | Line 170: | ||
#tweets{ | #tweets{ | ||
position: relative; | position: relative; | ||
- | top:- | + | top:-670px; |
left:642px; | left:642px; | ||
width: 280px; | width: 280px; | ||
Line 175: | Line 176: | ||
#countdown{ | #countdown{ | ||
position: relative; | position: relative; | ||
- | top: - | + | top: -607px; |
left:642px; | left:642px; | ||
} | } | ||
Line 184: | Line 185: | ||
clear: both; | clear: both; | ||
position: relative; | position: relative; | ||
- | top: | + | top: -500px; |
left: -70px; | left: -70px; | ||
width: 1005px; | width: 1005px; | ||
Line 212: | Line 213: | ||
margin-left: auto; | margin-left: auto; | ||
} | } | ||
+ | |||
+ | #exp1{ | ||
+ | position: relative; | ||
+ | top:-310px; | ||
+ | left:-58px; | ||
+ | background-color: #e6e6e6; | ||
+ | padding: 10px 10px 10px 10px; | ||
+ | width: 308px; | ||
+ | } | ||
+ | |||
+ | #exp2{ | ||
+ | position: relative; | ||
+ | top:-405px; | ||
+ | left: 288px; | ||
+ | background-color: #e6e6e6; | ||
+ | padding: 10px 10px 10px 10px; | ||
+ | width: 308px; | ||
+ | } | ||
</style> | </style> | ||
Line 345: | Line 364: | ||
<a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Notebook"><img id="notebutt" src="https://static.igem.org/mediawiki/2014hs/9/95/Notebook.png" width="300px" height="300px"></a> | <a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Notebook"><img id="notebutt" src="https://static.igem.org/mediawiki/2014hs/9/95/Notebook.png" width="300px" height="300px"></a> | ||
+ | <div id="exp1"> | ||
+ | <p>Click here to see the introductory video we used to familiarize ouselves with what we would be researching. </p> | ||
+ | </div> | ||
+ | |||
+ | <div id="exp2"> | ||
+ | <p>Here is a record of our. We also want to thank everybody who helped us along the way!</p> | ||
+ | </div> | ||
Revision as of 03:59, 21 June 2014
Choking Cancer
Every year approximately eight million people die of cancer, and an additional fourteen million are diagnosed with the disease. The World Heath Organization predicts that without immediate action these numbers will increase by eighty percent by the year 2030.
Cancer needs an abundant source of oxygenated blood to grow. To achieve this cancer cells release angiogenic factors that promote vascular growth. Without these factors, cancer is unable to survive. Consequently, current treatments focus on targeting/inhibiting the angiogenic factors released by cancer cells. Targeted therapy has also been a successful treatment option.
Our project aims to combine these two therapeutic approaches to create a synthetic biological machine that seeks out cancer cells and inhibits angiogenesis. We plan to design a bacterium that in the presence of cancer cells secretes an anti-angiogenic factor. This will inhibit the growth of the capillary system that is crucial for cancer cell survival.